Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison IncfiledCriticalAyerst Mckenna and Harrison Inc
Priority to FR921636ApriorityCriticalpatent/FR1433310A/fr
Priority to FR931254Aprioritypatent/FR2610M/fr
Application grantedgrantedCritical
Publication of FR1433310ApublicationCriticalpatent/FR1433310A/fr
Nouveaux médicaments constitués par le 5-[3'-(4-phényl-4-carbéthoxypipéridine) propylidene] dibenzo [a,d] [1,4] cycloheptadiene et ses sels d'addition acides.